Insider

Cardinal Health reports $67.5 billion in first-quarter revenue

Cardinal Health reported first-quarter fiscal 2027 revenue of $67.5 billion, a 5.5% increase year-over-year. The quarter ended September 30, 2026.

Verified against 4 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
Large industrial warehouse with blue gates and road
Photo by Mathias Reding on Unsplash
$67.5 billion
Quarterly revenue
5.5%
Revenue growth, y/y
$500 million
Share repurchases

Key points

  • During the first quarter, Cardinal Health completed a $500 million share repurchase.
  • Profit in the Global Medical Products and Distribution segment fell 28% year-over-year to $33 million, with revenue flat at $3.2 billion.

Financial results and strategic updates

During the first quarter, Cardinal Health completed a $500 million share repurchase. The company signed a binding letter of intent to extend distribution agreements with CVS Health. It also announced $1.0 billion in additional uncommitted revolving credit facilities, a pool of capital for operating needs.

In October 2026, the company reported that the agreement with CVS Health extends until June 2032. This extension reflects the current scope of distribution services.

Revenue by quarter, $B

59.9Q4 '24*0.7%52.3Q1 '251.1%55.3Q2 '251%54.9Q3 '251.3%60.2Q4 '25*0.7%64Q1 '261%65.6Q2 '261.1%67.5Q1 '271.1%
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.

Risks and uncertainties

Profit in the Global Medical Products and Distribution segment fell 28% year-over-year to $33 million, with revenue flat at $3.2 billion. Terms of the updated agreement with CVS Health and their impact on future revenue were not disclosed.

Key performance metrics

Profitability trends in the Global Medical Products and Distribution segment are key for evaluating company performance. Information on the use of credit facilities is also significant, as it reflects current liquidity.

Original sources

  1. 8-K EX-99.1 filing, November 5, 2026November 5, 2026SHA-256 of our archived copy 9b06383e2bec…
  2. financial data (XBRL)November 5, 2026SHA-256 of our archived copy ec164665e522…
  3. 8-K filing, October 1, 2026October 1, 2026SHA-256 of our archived copy 8a65adfb728a…
  4. 8-K EX-99.1 filing, October 1, 2026October 1, 2026SHA-256 of our archived copy f37e37875636…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards